A Public Health Solution to Hearing Loss Moves Forward
The Bloomberg School's Cochlear Center for Hearing and Public Health has advocated to make hearing aids more accessible and more affordable, as the FDA has now moved to do.
Policy brief: FDA REGULATION Q&A: THE HEARING AID REVOLUTION
ARTICLE: THE EAR-BRAIN CONNECTION. VIDEO: Age-Related Hearing Loss
Our Academic Program Offerings
Our programs welcome those from within and outside the traditional boundaries of public health. Whether you're a future college graduate, a midcareer public health leader, or someone looking to make a career change, we have a program for you.
Headlines
Monitoring the Monkeypox Response
With monkeypox case counts rising, metrics could tell us if the epidemiological picture is pointing in the right direction.
Study Finds Undiagnosed Diabetes in U.S. Less Than Half of Current Estimates
Analysis also suggests undiagnosed diabetes is more prevalent in certain subgroups, including older and obese adults, racial/ethnic minorities, and those without health care access.
Why TB Deserves Your Attention
Tuberculosis was the world’s biggest infectious disease killer—until COVID-19 came along.
Prediabetes Explained: An Under-the-Radar and Common Condition That Doesn’t Have to Lead to a Diabetes Diagnosis
A prediabetes diagnosis is not necessarily a precursor to diabetes. It’s an important intervention opportunity for a condition that is potentially reversible with modest weight loss through exercise and healthy eating habits.
Why Confirming The Origin of COVID-19 Matters
A new report confirming a Wuhan seafood market as SARS-CoV-2’s origin shines a light on the need for critical research to prevent future pandemics.
COVID-19 questions? We've got answers.
Our searchable COVID-19 Q&A database has a wealth of general information about coronaviruses, variants, prevention, immunity, and more.
Meet Our Faculty
Our faculty are world-renowned experts, and trusted advisers to our students, public health leaders, and the public.
Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.
Janice Bowie, PhD '97, MPH, is Chair of the Doctor of Public Health program and an expert in health disparities and community-based research methods.
James Kumwenda, MD, MSPH ’20, studies health leadership, health systems strengthening, and capacity strengthening in primary health care.
Brian Schwartz, MD, MS, GME ’90, uses environmental epidemiology to evaluate the drivers of sustainability health impacts, such as energy, agriculture, and built environments.
Why Choose the Johns Hopkins Bloomberg School of Public Health?
#1
Ranked by U.S. News & World Report since 1994
1st
and Largest School of Public Health
1,800+
Courses Offered
80+
Research Centers and Institutes
27K+
Alumni Living in over 160 Countries
90+
Degree Programs
40
Certificate Programs
4:1
Student-to-Primary-Faculty Ratio
Progress and Purpose
The midterm update of our 2019-2023 strategic plan describes accomplishments to date and identifies ongoing priorities.
Support Our Work
Our work is made possible in part by contributions from Bloomberg School donors.